US2012122760A1PendingUtilityA1

Novel lipids for transfection of nucleic acids

Assignee: GEBEYEHU GULILATPriority: May 22, 2003Filed: Oct 11, 2011Published: May 17, 2012
Est. expiryMay 22, 2023(expired)· nominal 20-yr term from priority
C07C 215/14C07C 217/28
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Cationic lipid compositions are provided that are useful for efficient delivery of macromolecules, such as nucleic acids, into a wide variety of eukaryotic cell types. Methods for using the compositions also are provided.

Claims

exact text as granted — not AI-modified
1 . What is claimed is:
 A lipid having the formula I or II:   
       
         
           
           
               
               
           
         
         wherein in compounds of formula I: 
         X is N(R 4 R 5 R 6 ) or dialkylphosphatidyl, or X is 
       
       
         
           
           
               
               
           
         
         Y and Z independently are selected from the group consisting of alkoxy, alkanoyloxy, alkylamine, alkyl urethane and alkyl guanidine 
         R 1  and R 2  independently are selected from the group consisting of hydrogen, C 1 -C 6  alkyl, alkylamine, alkylaminoalcohol, spermiyl, spermidyl and carboxyspermiyl, 
         R 3  is H or C 1 -C 4  alkyl, 
         R 4 , R 5 , and R 6  independently are selected from the group consisting of hydrogen, alkyl, alkenyl, aryl and alkylaryl, provided that at least one of R 4 , R 5 , and R 6  is a long chain alkyl or alkenyl, 
         W is short chain alkyl or alkylamino, and 
         R 7  is a negative charge or short chain alkyl, 
         and wherein in compounds of formula II, X 1  is selected from the group consisting of (CH 2 ) n , (CHOH) n , —NH—, —O—, a polyether, an ester linkage —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC(═NH)NH, 
         Y 1  is selected from the group consisting of (CH 2 ) n , a polyether, NHCO, —CO—, and a polyamide, 
         Y 2  is selected from the group consisting of (CH 2 ) n , —NH—, —O—, a polyether, an ester linkage, —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC(═NH)NH, 
         Z 1  and Z 2  are independently selected from the group consisting of hydrogen, primary alkylamine, secondary alkylamine, tertiary alkyl amine, quaternary alkylamine, amino alcohol, alkyl polyamine, spermidine, spermine, carboxy spermine, guanidinium, pyridinium, pyrollidinium, piperidinyium amino acyl, peptidyl, and protein, 
         R 8 , R 9 , R 10 , and R 11  are independently absent or selected from the group consisting of hydrogen, straight chain C 1 -C 20  alkyl, branched alkyl, cyclalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC(═NH)NH], and 
         n=1-12. 
       
     
     
         2 . The composition comprising a lipid according to  claim 1  and a macromolecule. 
     
     
         3 . The composition according to  claim 2  wherein said macromolecule is a nucleic acid. 
     
     
         4 . The composition according to  claim 3 , wherein said nucleic acid comprises a DNA molecule. 
     
     
         5 . The composition according to  claim 4 , wherein said DNA molecule is a double stranded DNA molecule. 
     
     
         6 . The composition according to  claim 5 , wherein said DNA molecule is a plasmid. 
     
     
         7 . The composition according to  claim 6 , wherein said plasmid encodes an RNA molecule that is self complementary and that forms a region of double stranded RNA. 
     
     
         8 . The composition according to  claim 3 , wherein said nucleic acid comprises an RNA molecule. 
     
     
         9 . The composition according to  claim 8 , wherein said RNA molecule is a double stranded RNA molecule. 
     
     
         10 . The composition according to  claim 9 , wherein said RNA molecule is an siRNA. 
     
     
         11 . A method of introducing a nucleic acid into a cell, comprising contacting a eukaryotic cell with a composition according to  claim 3 . 
     
     
         12 . A kit for transfecting a cell, comprising a lipid according to  claim 1 . 
     
     
         13 . A composition comprising a lipid according to  claim 1  and a peptide or protein. 
     
     
         14 . A method of introducing a peptide or protein into a cell, comprising contacting a eukaryotic cell with a composition according to  claim 13 . 
     
     
         15 . A kit for introducing a desired peptide or protein into a cell, comprising a lipid according to  claim 1 . 
     
     
         16 . A method of introducing a desired molecule into a tissue, comprising contacting said tissue with a composition comprising said desired molecule and a lipid according to  claim 1 . 
     
     
         17 . A method according to  claim 16 , wherein said desired molecule is a nucleic acid, a peptide, or a protein.

Join the waitlist — get patent alerts

Track US2012122760A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.